Does inflating an AMS 700 inflatable penile prosthesis compress the dorsal penile nerve, resulting in reduced penile sensation and inability to achieve orgasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dorsal Penile Nerve Compression During AMS 700 Inflation: Addressing Sensation and Orgasm Concerns

The concern that inflating the AMS 700 compresses the dorsal penile nerve causing reduced sensation and inability to orgasm is not supported by objective electrophysiological evidence, though subjective sensory changes are reported by some patients and significantly impact sexual satisfaction when they occur.

Evidence on Penile Sensation After Inflatable Penile Prosthesis

Objective Neurophysiological Data

The most direct evidence comes from electrophysiological testing of penile nerve function. A prospective study using penile electromyography (EMG) in 27 patients (including 3 with AMS 700 CXR devices) found no significant loss of nerve conduction velocity at 3 or 6 months post-implantation 1. Mean nerve conduction values were 29.85 m/s preoperatively, 27.64 m/s at 3 months, and 24.80 m/s at 6 months, with no statistically significant differences (p=0.607 and p=0.276 respectively). This objective data contradicts the hypothesis of mechanical nerve compression from device inflation.

Patient-Reported Sensory Changes

However, subjective sensory perception tells a different story. A 2026 study of 159 IPP patients found that patient-reported penile sensory loss was the single strongest independent predictor of lower sexual satisfaction scores (β = -17.72; P < .001) 2. Importantly, this sensory perception was not associated with surgical approach, device type, complications, or malfunction—suggesting the mechanism is more complex than simple mechanical compression during inflation.

Clinical Implications and Management

Pre-Operative Counseling

The AUA guidelines mandate that patients considering prosthesis implantation be informed of "differences from the normal flaccid and erect penis, including penile shortening" 3. While the guidelines don't specifically mention sensory changes, this should be incorporated into informed consent discussions given the impact on satisfaction.

Common Causes of Dissatisfaction

Historical data on AMS 700 devices identifies the actual drivers of patient dissatisfaction 4:

  • Pain (most common complaint)
  • Penile appearance concerns
  • Need for multiple procedures
  • Perceived penile shortening and reduced girth 5

Notably, 83% of patients and 70% of partners reported satisfaction with the AMS 700 in long-term follow-up 4, with more recent data showing median IIEF-5 scores of 21.46 and EDITS scores of 73.11, indicating high satisfaction levels 6.

Addressing Orgasmic Function

Orgasmic dysfunction after IPP is not attributed to nerve compression from inflation. The device provides mechanical rigidity for penetration but does not directly interfere with the neurovascular pathways responsible for orgasm, which involve different anatomical structures than those affected by cylinder inflation. If orgasmic difficulties occur, evaluate:

  • Pre-existing orgasmic dysfunction (often present before surgery)
  • Psychological adjustment to the prosthesis
  • Partner dynamics and expectations
  • Concurrent medications affecting sexual function
  • Hormonal status (testosterone levels)

Practical Recommendations

If a patient reports reduced sensation or orgasmic difficulty after AMS 700 implantation:

  1. Verify proper device function - ensure complete inflation/deflation cycling
  2. Assess for surgical complications - infection, erosion, or malposition can cause discomfort that patients may describe as "numbness"
  3. Evaluate psychological factors - adjustment to the prosthesis takes time; consider referral for psychosexual counseling 7
  4. Check testosterone levels - hypogonadism affects both sensation and orgasmic function
  5. Review expectations - the prosthesis provides rigidity, not restoration of natural erectile physiology

Important Caveats

The discrepancy between objective nerve testing (showing no damage) and subjective patient reports (indicating sensory changes) suggests that perceived sensory loss may reflect altered proprioception, psychological adjustment, or changes in penile biomechanics rather than actual nerve compression 2, 1. The inflated cylinders do increase penile girth and alter tissue dynamics, which could change sensory feedback without damaging nerves.

Device inflation does not mechanically compress the dorsal neurovascular bundle in a way that causes permanent nerve damage, as the cylinders are positioned within the corpora cavernosa, not dorsally where the nerves run 8. The dorsal nerves remain superficial to Buck's fascia and are not in the path of cylinder expansion.

References

Research

Long term patient satisfaction and quality of life with AMS700CX inflatable penile prosthesis.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2013

Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2003

Related Questions

At five months after AMS 700 LGX penile prosthesis implantation, is it necessary to continue the twice‑daily 30‑minute cycling routine?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What review of systems should be performed for an inpatient on warfarin who presents with dizziness?
What are the dosing and monitoring guidelines for desmopressin (DDAVP) in children with primary monosymptomatic nocturnal enuresis and in patients with central diabetes insipidus?
How should cough be managed in an otherwise healthy adult with a common cold?
When should a smoker undergo low‑dose chest CT for lung‑cancer screening and when is a diagnostic chest CT indicated?
In an elderly patient with advanced dementia, dysphagia, and a focal infiltrate in the dependent lung zones (aspiration pneumonia), should ceftriaxone be used, and what dosing and adjunctive therapy are appropriate?
In a patient with recurrent urinary tract infections who has recently completed levofloxacin and ciprofloxacin therapy that was culture‑sensitive, what should be ordered next?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.